229 related articles for article (PubMed ID: 37178737)
21. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis.
Nones K; Waddell N; Wayte N; Patch AM; Bailey P; Newell F; Holmes O; Fink JL; Quinn MCJ; Tang YH; Lampe G; Quek K; Loffler KA; Manning S; Idrisoglu S; Miller D; Xu Q; Waddell N; Wilson PJ; Bruxner TJC; Christ AN; Harliwong I; Nourse C; Nourbakhsh E; Anderson M; Kazakoff S; Leonard C; Wood S; Simpson PT; Reid LE; Krause L; Hussey DJ; Watson DI; Lord RV; Nancarrow D; Phillips WA; Gotley D; Smithers BM; Whiteman DC; Hayward NK; Campbell PJ; Pearson JV; Grimmond SM; Barbour AP
Nat Commun; 2014 Oct; 5():5224. PubMed ID: 25351503
[TBL] [Abstract][Full Text] [Related]
22. The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells.
Hansen SN; Ehlers NS; Zhu S; Thomsen MB; Nielsen RL; Liu D; Wang G; Hou Y; Zhang X; Xu X; Bolund L; Yang H; Wang J; Moreira J; Ditzel HJ; Brünner N; Schrohl AS; Stenvang J; Gupta R
BMC Genomics; 2016 Jun; 17():442. PubMed ID: 27277198
[TBL] [Abstract][Full Text] [Related]
23. Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner.
Gilad O; Nabet BY; Ragland RL; Schoppy DW; Smith KD; Durham AC; Brown EJ
Cancer Res; 2010 Dec; 70(23):9693-702. PubMed ID: 21098704
[TBL] [Abstract][Full Text] [Related]
24. Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma.
Kawano H; Saeki H; Kitao H; Tsuda Y; Otsu H; Ando K; Ito S; Egashira A; Oki E; Morita M; Oda Y; Maehara Y
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S696-702. PubMed ID: 24898425
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies.
Lee JK; Choi YL; Kwon M; Park PJ
Annu Rev Pathol; 2016 May; 11():283-312. PubMed ID: 26907526
[TBL] [Abstract][Full Text] [Related]
26. Activation of NRF2 by APE1/REF1 is redox-dependent in Barrett's related esophageal adenocarcinoma cells.
Sriramajayam K; Peng D; Lu H; Zhou S; Bhat N; McDonald OG; Que J; Zaika A; El-Rifai W
Redox Biol; 2021 Jul; 43():101970. PubMed ID: 33887608
[TBL] [Abstract][Full Text] [Related]
27. Comparative genomic hybridization of esophageal adenocarcinoma and squamous cell carcinoma cell lines.
Su M; Chin SF; Li XY; Edwards P; Caldas C; Fitzgerald RC
Dis Esophagus; 2006; 19(1):10-4. PubMed ID: 16364037
[TBL] [Abstract][Full Text] [Related]
28. TGM2: a cell surface marker in esophageal adenocarcinomas.
Leicht DT; Kausar T; Wang Z; Ferrer-Torres D; Wang TD; Thomas DG; Lin J; Chang AC; Lin L; Beer DG
J Thorac Oncol; 2014 Jun; 9(6):872-81. PubMed ID: 24828664
[TBL] [Abstract][Full Text] [Related]
29. PARI overexpression promotes genomic instability and pancreatic tumorigenesis.
O'Connor KW; Dejsuphong D; Park E; Nicolae CM; Kimmelman AC; D'Andrea AD; Moldovan GL
Cancer Res; 2013 Apr; 73(8):2529-39. PubMed ID: 23436799
[TBL] [Abstract][Full Text] [Related]
30. A new class of ultrafine anaphase bridges generated by homologous recombination.
Chan YW; West SC
Cell Cycle; 2018; 17(17):2101-2109. PubMed ID: 30253678
[TBL] [Abstract][Full Text] [Related]
31. Tumorigenic effects of TLX overexpression in HEK 293T cells.
Parris TZ; Vizlin-Hodzic D; Salmela S; Funa K
Cancer Rep (Hoboken); 2019 Oct; 2(5):e1204. PubMed ID: 32721119
[TBL] [Abstract][Full Text] [Related]
32. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
33. Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer.
Meyer F; Becker S; Classen S; Parplys AC; Mansour WY; Riepen B; Timm S; Ruebe C; Jasin M; Wikman H; Petersen C; Rothkamm K; Borgmann K
Cells; 2020 Jan; 9(1):. PubMed ID: 31963582
[TBL] [Abstract][Full Text] [Related]
34. Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer.
Vukovic B; Beheshti B; Park P; Lim G; Bayani J; Zielenska M; Squire JA
Cytogenet Genome Res; 2007; 116(1-2):1-11. PubMed ID: 17268171
[TBL] [Abstract][Full Text] [Related]
35. Tumor Evolution and Therapeutic Choice Seen through a Prism of Circulating Tumor Cell Genomic Instability.
Tayoun T; Oulhen M; Aberlenc A; Farace F; Pawlikowska P
Cells; 2021 Feb; 10(2):. PubMed ID: 33562741
[TBL] [Abstract][Full Text] [Related]
36. Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation.
Coleman WB; Tsongalis GJ
Clin Chem; 1995 May; 41(5):644-57. PubMed ID: 7729041
[TBL] [Abstract][Full Text] [Related]
37. Lead facilitates foci formation in a Balb/c-3T3 two-step cell transformation model: role of Ape1 function.
Hernández-Franco P; Silva M; Franco R; Valverde M; Rojas E
Environ Sci Pollut Res Int; 2018 Apr; 25(12):12150-12158. PubMed ID: 29455351
[TBL] [Abstract][Full Text] [Related]
38. Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma.
Ströbel T; Madlener S; Tuna S; Vose S; Lagerweij T; Wurdinger T; Vierlinger K; Wöhrer A; Price BD; Demple B; Saydam O; Saydam N
Sci Rep; 2017 Aug; 7(1):9674. PubMed ID: 28852018
[TBL] [Abstract][Full Text] [Related]
39. Mapping of homozygous deletions in verified esophageal adenocarcinoma cell lines and xenografts.
Boonstra JJ; van Marion R; Douben HJ; Lanchbury JS; Timms KM; Abkevich V; Tilanus HW; de Klein A; Dinjens WN
Genes Chromosomes Cancer; 2012 Mar; 51(3):272-82. PubMed ID: 22081516
[TBL] [Abstract][Full Text] [Related]
40. Tumor-associated APE1 variant exhibits reduced complementation efficiency but does not promote cancer cell phenotypes.
Illuzzi JL; McNeill DR; Bastian P; Brenerman B; Wersto R; Russell HR; Bunz F; McKinnon PJ; Becker KG; Wilson DM
Environ Mol Mutagen; 2017 Mar; 58(2):84-98. PubMed ID: 28181292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
